Ventas/$VTR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ventas
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Ticker
$VTR
Sector
Primary listing
NYSE
Employees
498
Headquarters
Website
Ventas Metrics
BasicAdvanced
$32B
162.56
$0.43
0.89
$1.86
2.75%
Price and volume
Market cap
$32B
Beta
0.89
52-week high
$71.36
52-week low
$56.68
Average daily volume
2.5M
Dividend rate
$1.86
Financial strength
Current ratio
0.719
Quick ratio
0.485
Long term debt to equity
111.346
Total debt to equity
111.346
Dividend payout ratio (TTM)
413.76%
Interest coverage (TTM)
1.40%
Profitability
EBITDA (TTM)
2,017.388
Gross margin (TTM)
41.83%
Net profit margin (TTM)
3.62%
Operating margin (TTM)
15.88%
Effective tax rate (TTM)
-32.74%
Revenue per employee (TTM)
$10,590,000
Management effectiveness
Return on assets (TTM)
2.05%
Return on equity (TTM)
1.82%
Valuation
Price to earnings (TTM)
162.555
Price to revenue (TTM)
5.721
Price to book
2.75
Price to tangible book (TTM)
3.02
Price to free cash flow (TTM)
24.534
Free cash flow yield (TTM)
4.08%
Free cash flow per share (TTM)
2.847
Dividend yield (TTM)
2.66%
Forward dividend yield
2.75%
Growth
Revenue change (TTM)
12.89%
Earnings per share change (TTM)
-210.27%
3-year revenue growth (CAGR)
9.49%
10-year revenue growth (CAGR)
5.64%
3-year earnings per share growth (CAGR)
120.76%
10-year earnings per share growth (CAGR)
-12.06%
3-year dividend per share growth (CAGR)
1.10%
10-year dividend per share growth (CAGR)
-4.96%
What the Analysts think about Ventas
Analyst ratings (Buy, Hold, Sell) for Ventas stock.
Bulls say / Bears say
Ventas’s diversified healthcare portfolio of nearly 1,400 properties across senior housing, medical office, hospitals, and life science assets spreads risk and provides stable, multi-segment cash flows (Reuters).
Investors assign a premium to Ventas’s asset quality and growth prospects, as evidenced by its price-to-book ratio of 2.66 times, well above sector averages (Reuters).
Ventas generated $1.12 billion in operating cash flow in the latest reported period, highlighting its strong cash generation capacity to support dividends and reinvestment (Reuters).
High leverage exposes Ventas to rising interest costs, with total debt of $13.5 billion representing over 54 percent of its $24.7 billion asset base (Reuters).
U.S. REIT sector trades at a price-to-net asset value multiple of 3.8, well above its historical average of less than 2.5, raising the risk of valuation compression if market sentiment shifts (Reuters).
Shares of New York-based REITs fell about 5 percent on concerns over proposed rent freezes in the city, underscoring regulatory risks that could constrain revenue growth in rent-regulated segments (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.
Ventas Financial Performance
Revenues and expenses
Ventas Earnings Performance
Company profitability
Ventas News
AllArticlesVideos
Ventas Provides BofA Securities 2025 Global Real Estate Conference Presentation Materials
Business Wire7 days ago
Ventas Releases 2024-2025 Corporate Sustainability Report
Business Wire1 week ago
Ventas to Participate in Investor Meetings at BofA Securities 2025 Global Real Estate Conference
Business Wire1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ventas stock?
Ventas (VTR) has a market cap of $32B as of September 16, 2025.
What is the P/E ratio for Ventas stock?
The price to earnings (P/E) ratio for Ventas (VTR) stock is 162.56 as of September 16, 2025.
Does Ventas stock pay dividends?
Yes, the Ventas (VTR) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $1.86 and the yield is 2.75%. Ventas has a payout ratio of 413.76% on a trailing twelve-month basis.
When is the next Ventas dividend payment date?
The next Ventas (VTR) dividend payment date is unconfirmed.
What is the beta indicator for Ventas?
Ventas (VTR) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.